Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.81 USD | +5.88% | +9.18% | +2.78% |
Financials (USD)
Sales 2024 * | 30.79M | Sales 2025 * | 11.82M | Capitalization | 75.7M |
---|---|---|---|---|---|
Net income 2024 * | -63M | Net income 2025 * | -84M | EV / Sales 2024 * | 2.46 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6.4 x |
P/E ratio 2024 * |
-1.65
x | P/E ratio 2025 * |
-1.56
x | Employees | 165 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.46% |
Latest transcript on HOOKIPA Pharma Inc.
1 day | +5.88% | ||
1 week | +9.18% | ||
Current month | +16.92% | ||
1 month | +18.49% | ||
3 months | +15.91% | ||
6 months | +82.37% | ||
Current year | +2.78% |
Managers | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Klaus Orlinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Chairman | 63 | 17-09-30 | |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.82 | +7.20% | 9 324 903 |
24-04-23 | 0.765 | +8.20% | 791,938 |
24-04-22 | 0.707 | -3.55% | 872,297 |
24-04-19 | 0.733 | -4.17% | 443,545 |
24-04-18 | 0.7649 | +0.31% | 172,841 |
Delayed Quote Nasdaq, April 24, 2024 at 01:03 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.78% | 75.7M | |
+25.70% | 672B | |
+25.87% | 570B | |
-5.65% | 360B | |
+16.03% | 321B | |
+8.62% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-9.00% | 149B |
- Stock Market
- Equities
- HOOK Stock